Fight the Fakes was delighted to present at PharmaConex in Egypt, the largest Africa’s pharmaceutical conference in Africa. The conference brings together stakeholders from across the pharmaceutical sector to exchange knowledge, explore innovations, and strengthen collaboration across the medicine supply chain.
For the first time at Pharmaconex, the discussion addressed substandard and falsified medical products, an important step in raising awareness of this persistent threat and its impact on patient safety across the continent.
The session was moderated by Razi Miliani, Fight the Fakes Alliance Goodwill Ambassador, and brought together:
-
Noha Abdelaziz, Fight the Fakes Lead at Newgiza University (NGU)
-
Dr Jules Charles Kébé, Vice President of the African Pharmaceutical Distribution Association (APDA)
Together, they explored how stronger data systems, more resilient supply chains, and sustained cooperation can help prevent substandard and falsified medical products from reaching patients.
The threat posed by SF medical products remains significant across Africa. Tackling it requires more than isolated interventions: it calls for reliable information, coordinated action, and collaboration among regulators, manufacturers, distributors, healthcare professionals, academic institutions, civil society, and patients.
The discussion highlighted several areas for continued action:
-
Improving the collection and use of data to identify risks and inform responses.
-
Strengthening supply chains so that medicines can be tracked and protected at every stage.
-
Sharing regional experiences and practical solutions.
-
Building sustained partnerships across the pharmaceutical and healthcare sectors.
Bringing this issue to the Pharmaconex platform was an important opportunity to place medicine quality and patient safety at the centre of conversations about Africa’s pharmaceutical future.
By working together, stakeholders can strengthen efforts to prevent SF medical products, support safer medicine supply chains, and ensure that patients receive the quality-assured products they need.
